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Abstract 
Polar expeditions have been associated with changes in the hypothalamic-pituitary-
testicular axis consistent with central hypogonadism (i.e. decreased testosterone, luteinising 
hormone [LH] and follicle stimulating hormone [FSH]). These changes are typically 
associated with body mass loss. Our aim was to evaluate whether maintenance of body mass 
during a Polar expedition could mitigate against the development of central hypogonadism. 
Male participants (n=22) from a 42-day expedition (British Services Antarctic Expedition 
2012 [BSAE]) volunteered to take part in the study. Body mass, body composition and 
strength data were recorded pre- and post-expedition in addition to assessment of serum 
testosterone, LH, FSH, thyroid hormones, insulin-like growth factor 1 (IGF-1) and trace 
elements. Energy provision and energy expenditure (EE) were assessed at mid- and end-
expedition.  
Daily energy provision was 6335±149 kcal.day-1. Estimated EE mid-expedition was 
5783±1690 kcal.day-1. Body mass a n d  percentage body fat did not change between pre- 
and post-expedition. Total testosterone (nmol/L) (14.0±4.9 vs. 17.3±4.0, p=0.006), 
calculated free testosterone (pmol/L) (288±82 vs. 350±70, p=0.003) and sex hormone 
binding globulin (SHBG, nmol/L) (33±12 vs. 36±11, p=0.023) concentrations increased. LH 
and FSH remained unchanged. Thyroid stimulating hormone (TSH, IU/L) (2.1±0.8 vs. 
4.1±2.1, p<0.001) and free triiodothyronine (T3, IU/L) (5.4±0.4 vs. 6.1±0.8, p<0.001) 
increased while free thyroxine (T4),  IGF-1 and trace elements remained unchanged. Hand-
grip strength reduced post-expedition but static lift strength was maintained. 
Maintenance of body mass and nutritional status appeared to negate the central 
hypogonadism previously reported from Polar expeditions. The elevated TSH and free T3 
were consistent with a previously reported “Polar T3 syndrome”. 
Key words: Gonadotrophic and thyroid hormones, Nutrition, Energy Balance, Antarctica, 
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Cold, BMI . 
Introduction 
Acute physiological stress, such as that associated with surgery (Lindh et al. 1992), burns 
(Lephart et al. 1987),  severe illness (Semple et al. 1980) or  completing an ultra-
endurance event (Tauler et al. 2014) are well recognised causes of a rapid reduction in  
testosterone. Similarly, arduous physical training may also affect the hypothalamic-
pituitary-testicular axis (Gomez-Merino et al. 2003, Alemany et al. 2008), with 
testosterone reported to decrease by 50-60% during United States Ranger and Marine 
training (Friedl et al. 2000, Alemany et al. 2008). The decrease in testosterone is 
usually associated with a concomitant decrease in luteinising hormone (LH) and follicle 
stimulating hormone (FSH), reflecting the development of central hypogonadism (Friedl 
et al. 2000, Sewani-Rusike et al. 2000).  This is most likely due to reduced 
hypothalamic Gonadotropin-releasing hormone (GnRH) secretion. When measures of 
energy balance and nutritional status were included in such studies, a significant energy 
deficit with reductions in body mass, fat free mass and body fat were frequently 
reported (Guezennec et al. 1994, Sewani-Rusike et al. 2000, Nindl et al.  2007, 
Alemany et al. 2008). 
Similar to endocrine responses to arduous physical training, the physical demands 
associated with Polar expeditions in the Arctic and Antarctica have also been associated 
with decreases in testosterone concentrations (Stroud et al. 1997, Gagnon et al. 2011, 
Johansen et al. 1991). These responses may also be due to central hypogonadism 
(Stroud et al. 1997). Again, loss of body mass seems a common factor, with a 25% 
reduction observed (albeit in only two volunteers) in the data reported by Stroud 
(Stroud et al. 1997), and a 10 kg loss reported by Gagnon (Gagnon et al. 2011). 
The physical demands of Polar expeditions may parallel the effects of intense physical 
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training, and similarly induce central hypogonadism in males secondary to body mass loss. 
However, very little is known about the pituitary-gonadal response to prolonged physical 
exercise whilst exposed to extreme cold, especially if body mass is conserved. Our aim 
was to evaluate whether consumption of the current British Army Cold Climate Ration 
(which has a greater energy content than conventional rations) during a Polar expedition 
could prevent significant weight loss. Our hypothesis was that maintaining energy provision 
at a level to prevent body mass loss on an Antarctic expedition might mitigate the potential 
for central hypogonadism to occur.  
5 
Materials and Methods 
Ethical Approval 
Ethical approval was obtained from the Ministry of Defence Research Ethics Committee 
(MODREC 090/GEN/09; Amendment-12). Written informed consent was obtained from 
all volunteers before data collection commenced and the study was conducted in 
accordance with the Declaration of Helsinki. 
Research Participants 
A cohort of 22 male participants, from the British Services Antarctic Expedition (2012) 
(BSAE), volunteered to take part in the study. This was a UK Joint Services expedition 
mounted to the mainland of the Antarctic Peninsula to undertake scientific exploration 
over 42 days in remote areas. It was organised to commemorate Captain Scott’s 1910–
1913 expedition. All volunteers were serving members of the UK Armed Forces and had 
been deemed medically fit to be part of the Expedition team. 
Schedule of investigations 
Percentage body fat was assessed in the UK 5 weeks before the expedition began, repeated 
in the Antarctic immediately prior to and following the expedition and on return to the UK 
seven days later. Body mass, height and derived body mass index were assessed pre-
expedition in the UK, immediately following the expedition in the Antarctic and on return 
to the UK. Blood samples were taken in the UK 5 weeks before the expedition began and 
immediately on return to the UK seven days after the expedition had finished. Strength 
measures were also taken in the UK 5 weeks before the expedition and immediately on 
return to the UK. 
Dietary Energy Provision 
All participants consumed the UK Ministry of Defence (MOD) Cold Climate Ration 
(CCR) throughout the expedition. The CCR is comprised of ten daily menu variants 
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providing a mean (SD) energy provision of 6335±149 kcal.  Of this total energy 
provision, 50–60% of the energy is provided as carbohydrates, 7–11% as protein, and 
30–37% as fat (Vestey Foods UK Ltd., Croydon, UK). 
Energy Expenditure 
A Task Analysis Questionnaire (TAQ) was administered at the mid- and end-points of 
the expedition over two five-day periods. Using daily recall, this method required 
volunteers to detail and describe their activities each hour over a 24-h period for two 
blocks of five days. Information from the TAQ was coded, whereby working and non-
working activities were assigned a Metabolic Equivalent (MET) value. Each activity 
performed throughout a 24-h observation period was assigned a MET value and a 24-h 
mean MET value calculated. A MET value of between 1.0–1.5 would indicate 
sedentary activity, 1.6–2.9 would equate to light-intensity, 3.0–5.9 would equate to 
moderate intensity activity, and ≥ 6.0 would equate to vigorous intensity. This mean 
MET value was then multiplied by a participant’s body mass (kg), and the duration of the 
collection period (h), to provide estimated energy expenditure as previously described 
(Ainsworth et al. 2011). 
Anthropometric Assessment 
Anthropometric measures were taken according to the schedule above. Body mass, 
height and skinfolds were measured. BMI was calculated from the body mass and 
height measurements. Percent body fat was determined according to the method of 
Durnin and Womersley w i t h  s k i n f o l d  m e a s u r e m e n t s  t a k e n  a t  t h e  b i c e p s ,  
t r i c e p s ,  s u b s c a p u l a r  a n d  s u p r a - i l i a c  s i t e s  (Durnin and Womersley 1974). 
Biochemical Assays 
A 7 ml blood sample was drawn from participants seated and rested by medical personnel 
using serum separation vacutainers according to the schedule above. Serum was allowed to 
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clot for a minimum of 30 minutes but no longer than 60 minutes. After centrifugation serum 
was stored in duplicate plastic 1.5-ml Eppendorf tubes at -80 0C. SHBG (nmol/L), LH 
(IU/L), FSH (IU/L) and TSH (mIU/L) were analysed on the Roche Modular System (Roche 
Diagnostics, Lewes, UK) by two-site sandwich immunoassay using electro 
chemiluminesence technology. Testosterone (nmol/L), free T3 (FT3, pmol/L) and free 
thyroxine (FT4, pmol/L) were also analysed on the Roche Modular System but using 
competition immunoassay with albumin (g/L) measured using an endpoint colourimetric 
method (bromcreosol green). Testosterone and SHBG were used to calculate free testosterone 
(pmol/L) by the equation: {[(SHBG - T + 23)2 + (92 x T)] - (SHBG - T + 23)}/0.046 
(Vermeulen et al. 1999). The somatotroph axis was assessed by assay of insulin-like growth 
factor-1 (IGF-1, nmol/L). Assay of IGF-1 was based on chemiluminescence technology using 
the IDS Isys instrumentation (calibrated to the new WHO international standard).  
Trace element assays 
The same serum sample was used to assay magnesium, zinc, copper and selenium pre- and 
post-expedition in order to reflect micronutrient status. 
Strength assessment 
Each test was preceded by a standardised demonstration and an explanation of the test 
method. Hand-grip strength was measured with volunteers maintaining a standing position, 
and being requested to exert a maximal, isometric force (measured in kg) in the forearms 
using a hand-grip dynamometer (Takei Model 5401, Cranlea, UK).  Following 
familiarisation, volunteers undertook three repetitions of the test, separated by 30 s rest, with 
both hands, where the dominant hand was recorded. Static lift strength was evaluated using 
an isometric dynamometer (Model 5402, Cranlea, UK).  From the dead lift position, 
volunteers were required to exert a maximal, isometric force in the legs, buttock and back 
muscles, and the maximum force (kg force) generated was recorded.  Following a practice 
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effort at 50% of maximum voluntary contraction, volunteers undertook three repetitions of 
the test separated by 30 s rest.  The best effort was recorded as the volunteer’s score. 
Statistical Analysis 
Data are presented as means, with the standard deviation (SD) being reported in 
parentheses. Descriptive statistics were determined for the anthropometric and physical 
work data. Minimum and maximum values and confidence limits (±95%) were also 
determined. Differences between pre- and post-expedition measurements were 
investigated by Student’s paired T-test. Statistical significance was accepted at  the p<0.05 
level. 
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Results 
Due to the logistical challenges of such a study not all participants had all data points 
recorded. Paired data were available for 19-20 subjects. Participants were 36±7 (range 23-
48) years old with a height of 1.79±0.1 (range 1.65-1.89) m. Body mass, BMI and body 
fat percentage did not change between pre- and post-expedition in the UK (Table 1). 
Similarly, there were no differences in body fat percentage between the pre-ice and post-
expedition ice measures. Body mass (82.0±7.1 kg to 82.9±6.8 kg; p=0.011) and BMI 
(25.5±1.7 kg.m-2 to 25.8±1.8 kg.m-2; p=0.015) increased by modest amounts between 
post-expedition ice and post-expedition UK measures. 
Mean daily estimated energy expenditure and five-day mean values are presented at Table 
2 for the mid-point of the expedition. Significant variability in daily energy expenditure 
was due to variability in daily activity (an expedition day involving mountaineering was 
high expenditure compared to a rest day).  Estimated daily energy expenditure over 5 days 
was 5783 (1690) kcal.day-1 mid-expedition and 5604 (1534) kcal.day-1 at the end of the 
expedition. The mean energy provision available from rations at this time was 6335 (149) 
kcal.day-1. 
The testosterone (total and calculated free), FSH, LH and SHBG of volunteers pre- and 
post-expedition are presented at Table 3. Both total testosterone (p=0.006) and calculated 
free testosterone (p=0.003) increased between the pre- and post-expedition 
measurement points. There was also a slight rise in SHBG (p=0.023) but LH and FSH 
remained unchanged. TSH, free T3, free T4, IGF-1, albumin and protein data are 
shown at Table 4. There were increases in serum concentrations of TSH (p<0.0001) and 
free T3 (p<0.001) with free T4 remaining unchanged. Serum concentrations of total 
protein (p=0.014) and albumin (p=0.015) decreased between pre- and post-expedition. 
The trace elements magnesium, zinc, copper and selenium showed no change pre- and post-
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expedition and remained within the normal reference range. Data are presented at Table 5. 
Strength assessment revealed a decrease (P<0.01) in both dominant and non-dominant hand-
grip strength post-expedition but static lift strength, and static lift strength relative to body 
mass, were maintained. Data are presented in Table 6. 
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Discussion 
Polar expeditions still represent significant physical and physiological challenges to 
humans, being associated with extreme climate, rapid and unpredictable changes in local 
weather, as well as the arduous, rugged and geographically remote terrain. Moving 
through this environment requires intense physical effort, which is associated with high 
rates of daily energy expenditure. Consumption of the CCR facilitated maintenance of 
body mass and micronutrient status. Most studies investigating the physical responses to 
Polar expeditions have reported a decrease in body mass, with a concomitant reduction in 
circulating testosterone concentrations (Stroud et al. 1997, Gagnon et al. 2011, Johansen 
et al. 1991) in a pattern consistent with central hypogonadism (Stroud et al. 1997). 
In contrast, serum calculated free testosterone concentrations increased between pre and 
post-expedition in the present study. As total testosterone and SHBG concentrations also 
increased, the increase in free testosterone was due to a primary increase in testosterone, 
not a decrease in specific binding proteins. 
Estimated energy expenditure mid-expedition was 5783 (1690) kcal.day-1, whereas the 
ration provision was 6335 (149) kcal.day-1. It therefore seems likely that maintenance of 
energy status, as evidenced by conservation of body mass and percentage body fat, 
prevented a decrease in testosterone. Although albumin and protein concentrations 
decreased slightly, values remained well within the normal range. Unchanged IGF-1 
concentrations further support maintenance of energy status. It is known that IGF-1 
decreases dramatically when volunteers are in an energy deficient state (Friedl et al. 
1985, Livingstone 2013), such that IGF-1 has been proposed as a biomarker of nutritional 
status (Livingstone 2013). 
While conservation of body mass and body fat seem clearly able to prevent the onset of 
hypogonadism during Polar expeditions, the mechanism that led to an actual rise in 
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testosterone concentrations are less clear. It is known that there may be some circannual 
variation in testosterone during a year of exposure to Antarctica seasons (Sawhney et 
al.1998). The Antarctic seasons are the opposite of those of the Northern hemisphere, 
with peak summer from January to February, “autumn” in March, and winter from 
April to September. Sawhney et al. ( 1 998) reported increased testosterone 
concentrations during the early months of the visit in nine male volunteers during a 12-
month stay in Antarctica.  Testosterone concentrations peaked in April, with the lowest 
concentrations being recorded between July–August (i.e. the Antarctica winter). In 
Europe,  seasonal variation in testosterone concentrations has also been reported, with 
peak concentrations in July. However, peak LH concentrations occur in January, which 
would suggest that seasonal variation in testosterone is independent of pituitary 
regulation, and could be due to an independent testicular mechanism (Bellastella 1983). 
Wehr et al. (2010) reported a similar pattern, with nadir testosterone concentrations in a 
large European cohort in March, and peak values in August. More recent work supports 
an independent testicular mechanism (Bellastella et al. 2013), and it has been postulated 
that increased light levels would exert a positive effect on gonadal function, possibly 
through inhibition of melatonin secretion (Bellastella et al. 2014). 
It therefore seems reasonable to postulate that the maintenance of energy status during the 
expedition in the present study prevented the onset of central hypogonadism. Having left 
the low light intensity of a British winter (early January), t he increased light levels of  
Antarctica could have facilitated a rise in testosterone concentration due to a testicular 
mechanism. The expedition took place during the peak of the Antarctica summer with 
virtually 24- hour daylight, when such an effect would be expected to be maximal. 
Maintenance of testosterone concentrations in a polar environment may be beneficial in 
the acclimatisation to the cold. In vitro, testosterone has been shown to reduce lipolytic 
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activity in cultured brown adipose tissue (Monjo et al. 2003). Thus, if energy status was 
maintained in cold weather, an increase in testosterone could be a means of conserving 
fat mass to aid maintenance of body heat. Furthermore, an increase in testosterone would 
also be of benefit to erythropoiesis and protein synthesis, which may be advantageous 
when exercising or undertaking physical work in cold weather (Gonzales et al. 2009). 
Despite this rise in testosterone however hand-grip strength did reduce over the course of 
the expedition, though static lift strength was maintained. 
In the present study, TSH and free T3 increased between pre- and post-expedition 
measurements, whilst free T4 remained unchanged. This pattern of increased thyroid 
activity was consistent with the “Polar T3 Syndrome” reported previously following 
longer Antarctica exposure (Do et al. 1996). Free T3 is an important regulator of 
metabolic rate and thermal control, such that an increase in T3 with cold exposure 
would be a physiologically consistent response. The Polar T3 Syndrome has previously 
been reported after several months of residence in Antarctica. As such, the changes 
observed in the present study after 42-days exposure represents a novel finding. 
One of the limitations of our study was that baseline body mass and blood samples, due to 
logistical constraints, had to be taken five weeks prior to the expedition starting. While 
post-expedition blood samples were taken immediately on arrival back to the UK (at the 
airport) this was seven days after the expedition had finished. We cannot exclude these 
factors as being a bias in our results. 
 
Conclusion 
Energy status and body mass were maintained during the BSAE Polar expedition, and 
thus appeared to prevent the previously observed central hypogonadism. This finding has 
important implications, not only for expeditionary and military medicine, but also for 
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patients who may become malnourished through associated illness. In addition, it could be 
postulated that the rise in testosterone documented in the present study may be facilitated 
by increased sunlight exposure, possibly mediated by suppression of melatonin secretion. 
Finally, this study has provided further evidence of a “Polar T3 syndrome” that may be a 
beneficial adaptation to the cold. 
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Table 1: Physical Characteristics of participants pre- and post-expedition – in the UK and 
on the Ice Measures; Mean (SD), Minimum and Maximum Values and 95% Confidence 
Intervals (CI). 
 
 Body Mass (kg) BMI (kg.m-2) Body Fat (%) 
Pre-Expedition 
UK (n=20) 82.9 (7.8) 25.8 (1.7) 19.8 (3.5) 
Minimum 70.0 23.3 14.0 
Maximum 100.7 29.4 25.4 
95% CI 3.4 0.7 1.5 
Pre-Expedition 
Ice (n=19) - - 20.4 (3.3) 
Minimum - - 13.9 
Maximum - - 25.7 
95% CI - - 1.5 
Post-Expedition 
Ice (n=20) 82.0 (7.1) 25.5 (1.7) 19.2 (3.4) 
Minimum 67.4 22.7 12.1 
Maximum 94.6 29.4 26.0 
95% CI 3.1 0.7 1.5 
∆ Pre-Ice vs. Post-
Ice 0.0 0.0 1.2 
∆ Pre-UK vs. Post-
Ice -0.9 -0.3 -0.6 
Post Expedition 
UK (n=20) 82.9 (6.8) 25.8 (1.8) 19.8 (3.3) 
Minimum 68.9 22.8 13.3 
Maximum 95.6 30.3 26.1 
95% CI 3.0 0.8 1.5 
∆ Post-Ice vs. Post-
UK 
+0.9* +0.3* +0.6 
∆ Pre-UK vs. Post-
UK 
0.0 0.0 0.0 
 
Note:   * P<0.05 
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Table 2: Mean (SD) Metabolic Equivalent (MET) and estimated energy expenditure 
(EE) from MET of male volunteers over a 5-day observation period at the mid-point of 
the expedition. 
 
 
 
 Day-1 
(n=20) 
Day-2 
(n=19) 
Day-3 
(n=20) 
Day-4 
(n=20) 
Day-5 
(n=20) 
5-Day Mean 
(n=20) 
MET 3.6(1.4) 1.8(1.0) 3.7(1.6) 2.0(1.4) 3.5(1.8) 2.9(0.7) 
Min 1.0 1.0 1.0 1.0 1.0 1.5 
Max 6.7 4.4 6.7 5.2 6.0 4.7 
EE 
(kcal.day-1) 
7188 
(3058) 
3530 
(2129) 
7244 
(3227) 
3959 
(2842) 
6694 
(3284) 
5783 
(1690) 
Min 1941 1880 1988 1701 1848 2812 
Max 13727 8545 13209 10402 11132 9999 
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Table 3: Mean (SD) Gonadotrophic Hormones of Male Volunteers (n=20) pre- and post- 
expedition. 
 
 
Testosterone 
(nmol/L) 
Calculated Free 
Testosterone 
(pmol/L) 
SHBG 
(nmol/L) 
LH (IU/L) FSH (IU/L) 
Pre- 
Expedition      
Mean (SD) 14.0 (4.9) 288 (82) 33 (12) 4.4 (1.4) 4.8 (3.4) 
Min 7.4 113 12 2.0 2.0 
Max 27.2 394 66 8.0 16.6 
Post- 
Expedition      
Mean (SD) 17.3 (4.0)*1 350 (70)*2 36 (11)*3 4.4 (1.5) 4.9 (4.0) 
Min 13.1 258 20 1.9 2.1 
Max 30.1 527 68 7.6 18.9 
Normal Range 6.7 – 25.7 215 – 760 15 – 48 1.8 – 8.2 1.4 – 14.0 
 
Note: 
*1 Difference Pre- vs. Post- (P=0.006) (Paired T-test) 
*2 Difference Pre- vs. Post- (P=0.003) (Paired T-test) 
*3 Difference Pre- vs. Post- (P=0.023) (Paired T-test) 
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Table 4: Mean (SD) Thyroid Hormones (Thyroid Stimulating Hormone, TSH: Free 
Triiodothyronine, T3; and, T4), IGF-1, Total Protein and Albumin pre- and post-
expedition. 
 
 
TSH 
(mIU/L) 
T3 
(pmol/L) 
T4 
(pmol/L) 
IGF-1 
(nmol/L) 
Total 
Protein 
(g/L) 
Albumin 
(g/L) 
Pre-
Expedition 
2.1      
(0.8) 
5.4   
(0.4) 
16.7    
(1.3) 
24.1      
(5.6) 
77        
(3) 
51 
(2) 
Min 1.1 4.6 13.5 15.0 73 46 
Max 4.0 6.1 19.1 40.0 85 55 
Post-
Expedition 
4.1(2.1)*1 6.1(0.8)*2 16.4(1.8) 26.2(5.8) 75(4)*3 50(2)*4 
Min 1.9 5.0 14.1 16.0 64 46 
Max 10.9 7.8 20.5 41.0 81 55 
Normal 
Range 0.3–4.7 3.5–6.5 9.5–21.5 # 60–80 35–50 
 
 
Notes: 
# Reference values for IGF-1 differ depending on age: 17 – 18 y, 20 – 56 nmol/L; 19 – 20 y, 
21 –85 nmol/L; 21 – 25 y, 18 – 42 nmol/L; and 26 – 39 y, 15 – 37 nmol/L. 
 
*1 Difference Pre- vs. Post- (P=0.000) (Paired T-test) 
*2 Difference Pre- vs. Post- (P=0.000) (Paired T-test) 
*3 Difference Pre- vs. Post- (P=0.014) (Paired T-test) 
*4 Difference Pre- vs. Post- (P=0.015) (Paired T-test) 
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Table 5: Mean (SD) trace element (Magnesium, Zinc, Copper and Selenium) concentrations 
(n=20) pre- and post-expedition. 
 
 
 Magnesium 
(µmol.L-1) 
Zinc 
(µmol.L-1) 
Copper 
(µmol.L-1) 
Selenium 
(µmol.L-1) 
Pre-Expedition 
Mean (SD) 0.78 (0.07) 12.55 (1.23) 14.63 (2.05) 1.18 (0.13) 
Min 0.63 10.90 11.80 0.95 
Max 0.90 14.9 19.1 1.44 
Post-Expedition 
Mean (SD) 0.80 (0.05) 12.61 (1.38) 14.05 (1.76) 1.18 (0.13) 
Min 0.71 9.12 10.60 0.86 
Max 0.89 14.9 18.5 1.35 
Normal Range 0.65 – 1.00 11 – 24 11 – 120 0.89 – 1.65 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
26 
Table 6: Mean (SD) hand grip strength (dominant and non-dominant), static lift strength and 
static lift strength relative to body mass (n=20) pre- and post-expedition.   
 
 Hand-Grip Strength Static Lift Test 
 
Dominant 
(kg) 
Non-Dominant 
(kg) 
Static Lift  
(kg) 
Static Lift / 
Body Mass 
Pre-Expedition     
Mean (SD) 55.8 (6.7) 54.6 (7.0) 131.2 (25.1) 1.6 (0.3) 
Min 42.6 43.2 67.0 0.8 
Max 73.2 72.8 168.5 2.2 
Post-Expedition     
Mean (SD) 52.6 (4.8)** 50.7 (5.8)** 129.9 (21.4) 1.5 (0.5) 
Min 44.9 41.3 78.0 0.0 
Max 60.2 60.9 173.5 2.2 
 
Note: **P<0.01 
 
 
 
 
 
 
 
 
 
 
